Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joerg Herrmann

Showing results (1-10 of 269) with videos related to

Pageof 27
Sort By:
Cardiovascular Research|November 14, 2003
New kits on the blot--can we microarray the future of atherosclerosis?Joerg Herrmann
Cardiology Clinics|October 8, 2019
Common Vascular Toxicities of Cancer TherapiesJoerg Herrmann
Trends in Cardiovascular Medicine|October 22, 2016
Editorial commentary: On the evaluation of patients with chest pain: Who are the risk takers?Joerg Herrmann
European Heart Journal Open|June 30, 2025
Advance at a glance: contributions to cardio-oncologyJoerg Herrmann
Cardiovascular Research|July 16, 2010
Leave me alone: the right ventricle in anterior myocardial infarctionJoerg Herrmann
Oncology (Williston Park, N.Y.)|February 21, 2019
Detecting Cardiotoxicity in Cancer Patients Receiving VEGF InhibitorsJoerg Herrmann
European Heart Journal|September 24, 2005
Peri-procedural myocardial injury: 2005 updateJoerg Herrmann
Current Oncology Reports|April 22, 2016
Tyrosine Kinase Inhibitors and Vascular Toxicity: Impetus for a Classification System?Joerg Herrmann
Trends in Cardiovascular Medicine|December 3, 2014
Seeing is believing: new updates on coronary microvascular dysfunctionJoerg Herrmann
Nature Reviews. Cardiology|March 29, 2020
Vascular toxic effects of cancer therapiesJoerg Herrmann
Pageof 27

Showing results (1-10 of 269) with videos related to

Sort By:
Pageof 27
Cardiovascular Research|November 14, 2003
New kits on the blot--can we microarray the future of atherosclerosis?Joerg Herrmann
Cardiology Clinics|October 8, 2019
Common Vascular Toxicities of Cancer TherapiesJoerg Herrmann
Trends in Cardiovascular Medicine|October 22, 2016
Editorial commentary: On the evaluation of patients with chest pain: Who are the risk takers?Joerg Herrmann
European Heart Journal Open|June 30, 2025
Advance at a glance: contributions to cardio-oncologyJoerg Herrmann
Cardiovascular Research|July 16, 2010
Leave me alone: the right ventricle in anterior myocardial infarctionJoerg Herrmann
Oncology (Williston Park, N.Y.)|February 21, 2019
Detecting Cardiotoxicity in Cancer Patients Receiving VEGF InhibitorsJoerg Herrmann
European Heart Journal|September 24, 2005
Peri-procedural myocardial injury: 2005 updateJoerg Herrmann
Current Oncology Reports|April 22, 2016
Tyrosine Kinase Inhibitors and Vascular Toxicity: Impetus for a Classification System?Joerg Herrmann
Trends in Cardiovascular Medicine|December 3, 2014
Seeing is believing: new updates on coronary microvascular dysfunctionJoerg Herrmann
Nature Reviews. Cardiology|March 29, 2020
Vascular toxic effects of cancer therapiesJoerg Herrmann
Pageof 27